Premium
This is an archive article published on December 27, 2021

Covid: First ‘precautionary’ shots to those who got second jab 9 months ago

🔴 The decision to keep the interval between the second and third doses at nine months has been based on the findings of five scientific studies carried out by ICMR and the Translational Health Science and Technology Institute, Faridabad.

Healthcare workers collect swab samples in New Delhi on Sunday. (Express Photo: Praveen Khanna)Healthcare workers collect swab samples in New Delhi on Sunday. (Express Photo: Praveen Khanna)

When the “precautionary” dose of the coronavirus vaccine begins to be administered on January 10, the first recipients will likely be those older than 60 years with associated comorbidities, and those who got their second dose nine months previously, The Indian Express has learnt.

The decision to keep the interval between the second and third doses at nine months has been based on the findings of five scientific studies carried out by the Indian Council of Medical Research (ICMR) and the Translational Health Science and Technology Institute (THSTI), Faridabad, top government sources who were part of the deliberations, told The Indian Express.

The nine-month interval would mean the initial doses of the precautionary vaccine will be received by those who had got the second shots in the primary vaccination schedule by April 10 this year — that is, mainly the healthcare and frontline workers who were the first to be inoculated from January 16 onward.

Story continues below this ad

On March 1, India also began vaccinating those older than 60 years, and 45-plus with specified co-morbid conditions. As of May 1,  1.11 crore people had received both doses, according to Health Ministry data.

“The Co-win platform will automatically reflect who will be eligible for the precautionary dose. We have the numbers ready as to how many will be eligible from January 10. An announcement will be made in the next few days,” a top government official said.

The sources drew a distinction between the precautionary doses planned by India from January 10, and the “booster” shots that are being administered by several countries around the world, including the United States and United Kingdom.

In his address to the nation on Saturday night, the Prime Minister did not use the expression “booster”; he said three priority groups — healthcare workers, frontline workers, and those above 60 with associated comorbidities — would get a “precautionary dose” of the vaccine.

Story continues below this ad

“Two doses of a two-dose vaccine (such as Covishield or Covaxin) may not produce a sufficient level of antibodies in individuals who are immunocompromised or immunosuppressed — their primary vaccination is, therefore, deemed incomplete,” a source said.

“To complete the primary vaccination for this specific group of immunocompromised and immunosuppressed individuals, an additional shot is required.”

Globally, the words booster doses and additional doses refer to different things, the sources said. “Booster doses are used on a population-wide basis; they are administered irrespective of the physical (comorbidity) status of the beneficiary,” a source said.

“Since we (India) do not have extensive population-based data on a booster shot, we are, as a measure of abundant caution, giving vulnerable groups that are exposed or could be exposed to the virus, another shot, which is the precaution dose,” the source said.

Story continues below this ad

According to the sources, a few members of the National Technical Advisory Group on Immunization (NTAGI) were against the administration of booster doses due to “insufficient pan-India” data on waning immunity post the second dose across all age groups.

Kaunain Sheriff M is an award-winning investigative journalist and the National Health Editor at The Indian Express. He is the author of Johnson & Johnson Files: The Indian Secrets of a Global Giant, an investigation into one of the world’s most powerful pharmaceutical companies. With over a decade of experience, Kaunain brings deep expertise in three areas of investigative journalism: law, health, and data. He currently leads The Indian Express newsroom’s in-depth coverage of health. His work has earned some of the most prestigious honours in journalism, including the Ramnath Goenka Award for Excellence in Journalism, the Society of Publishers in Asia (SOPA) Award, and the Mumbai Press Club’s Red Ink Award. Kaunain has also collaborated on major global investigations. He was part of the Implant Files project with the International Consortium of Investigative Journalists (ICIJ), which exposed malpractices in the medical device industry across the world. He also contributed to an international investigation that uncovered how a Chinese big-data firm was monitoring thousands of prominent Indian individuals and institutions in real time. Over the years, he has reported on several high-profile criminal trials, including the Hashimpura massacre, the 2G spectrum scam, and the coal block allocation case. Within The Indian Express, he has been honoured three times with the Indian Express Excellence Award for his investigations—on the anti-Sikh riots, the Vyapam exam scam, and the abuse of the National Security Act in Uttar Pradesh. ... Read More

Stay updated with the latest - Click here to follow us on Instagram

Latest Comment
Post Comment
Read Comments
Advertisement
Loading Taboola...
Advertisement